<DOC>
	<DOCNO>NCT00698737</DOCNO>
	<brief_summary>This research study take place Wayne State University take 11 week complete . This treatment research study individual currently cocaine abuse dependence , may also heroin dependence . The purpose study test whether oral sustained release d-amphetamine ( SR-AMP ) safe effective placebo prevent relapse cocaine use individual abuse dependent upon cocaine . We also interest whether , patient dependent cocaine heroin , whether SR-AMP safe effective prevent cocaine relapse combination buprenorphine .</brief_summary>
	<brief_title>Treatment Study : Reducing Cocaine/Heroin Abuse With SR-Amphetamine Buprenorphine ( ARC )</brief_title>
	<detailed_description>Cocaine dependence , particularly combination heroin dependence , pose serious substantial public health , social , economic problem ( e.g. , high medical cost , crime , lose productivity ) . Cocaine heroin use disorder often co-occur , conjunction associate high rate medical psychiatric problem bad drug abuse treatment outcome . Many medication test , fail , treat cocaine dependence alone cocaine abuser also use heroin . This clinical trial test whether SR-AMP effective placebo prevent relapse cocaine use , use SR-AMP patient cocaine dependence , combination buprenorphine ( patient also dependent heroin ) . Participants first outpatient must come Jefferson Avenue Research Program three time per week ( e.g . Monday , Wednesday , Friday ) measure drug use drug-related symptom . This phase last least 2 week . Next , participant live inpatient research unit seven ( 7 ) consecutive night . During weeklong inpatient stay , addition receive SR-AMP placebo capsule , participant begin counsel treatment help prepare avoid relapse discharge inpatient unit . After inpatient stay , participant outpatient come Jefferson Ave. Research Program daily eight ( 8 ) week . Throughout eight week , three urine sample collect week ass illicit drug use , questionnaire relate drug symptom assess mood risk behavior give .</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Heroin Dependence</mesh_term>
	<mesh_term>Amphetamine</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Heroin</mesh_term>
	<criteria>Male nonpregnant nonlactating female 1855 year age seek treatment drug use . Females childbearing potential eligible participate use acceptable method birth control . All participant must free significant clinical abnormality base medical history , physical examination , ECG , screen laboratory test . Participants must weigh least 50kg ( 110lbs ) . Participants must meet DSMIV criterion current Cocaine Abuse Dependence , possibly Opioid Dependence , provide cocaine positive ( , opioid dependent , opioid positive ) urine sample . Participants exclude meet DSMIV criterion current Alcohol Sedative Abuse ( exclude current Alcohol Sedative Dependence ) . Participants must influence alcohol ( BAL &lt; .002 ) sign inform consent screen . Volunteers eligible study present psychiatric illness , neurological disease , cardiovascular disease , pulmonary disease , systemic disease , current substance dependence ( except cocaine , heroin nicotine ) . If cognitively impair , currently treat Cocaine Opioid Dependence , use prohibited medication , female pregnant , lactate , heterosexually active use medically approve birth control measure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Opioid</keyword>
	<keyword>Cocaine</keyword>
</DOC>